JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma.
Leukemia
; 28(2): 338-48, 2014 Feb.
Article
in En
| MEDLINE
| ID: mdl-23689514
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Janus Kinase 3
/
Lymphoma, Extranodal NK-T-Cell
/
Mutation
Type of study:
Observational_studies
Limits:
Aged80
Language:
En
Journal:
Leukemia
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2014
Document type:
Article